Results 241 to 250 of about 22,781,087 (321)

Artificial Intelligence Reshapes Creativity: A Multidimensional Evaluation

open access: yesPsyCh Journal, EarlyView.
ABSTRACT Artificial intelligence (AI) is reshaping creativity by challenging its long‐held status as a uniquely human faculty. This study uses bibliometric analysis to reveal AI’s evolution from a passive instrument to an active co‐creator that amplifies human intuition and expands creative possibilities.
Chenchen Zhang   +3 more
wiley   +1 more source

Cranial reconstruction in the literature: A CiteSpace visualized bibliometric analysis. [PDF]

open access: yesNeurosurg Rev
Barsch J   +5 more
europepmc   +1 more source

Validating a rapid algorithmic weed hazard ranking method

open access: yesPest Management Science, EarlyView.
Climatic suitability, weed‐related publication frequency and global occurrence data form (CPG) hazard scores for selected species in New Zealand plotted against weed hazard classifications from three independent assessments. Abstract Background Conventional weed risk assessments (WRAs) are time‐consuming and often constrained by species‐specific ...
Christopher E. Buddenhagen   +5 more
wiley   +1 more source

Global research landscapes of ALDH2 and cancer revealed by bibliometric analysis. [PDF]

open access: yesDiscov Oncol
Zhang T   +6 more
europepmc   +1 more source

Work stress and organizational commitment: a bibliometric analysis and research Agenda.

open access: green
Monique Nadège HAMENI KAYE   +2 more
openalex   +1 more source

Global research trends and hotspots in Parkinson’s disease psychosis: a 25-year bibliometric and visual analysis

open access: gold
Jianhong Wu   +7 more
openalex   +1 more source

Evaluation of the PK/PD Changes on MASLD‐Related Population—An Example From Simultaneous Acetaminophen Parent‐Metabolite PBPK/PD Modeling

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) may exhibit altered pharmacokinetics (PK) and pharmacodynamics (PD) of drugs compared with healthy populations. However, no physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model has been specifically developed for MASLD.
Shanshan Zhao, Lan Zhang
wiley   +1 more source

Home - About - Disclaimer - Privacy